Modelled DT Structure
Method: homology modeling
Template PDB: 4ZW9_A
Identity: 94.737%
Minimized Score: -1440.603 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0256 | ||||
| Gene Name | SLC2A14 | ||||
| Protein Name | Glucose transporter type 14 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 4ZW9_A Identity: 94.737% Minimized Score: -1440.603 kcal/mol Detail: Structure Info |
||||
| Synonyms | GLUT-14; GLUT14; SLC2A14; SLC2A3P3; Solute carrier family 2, facilitated glucose transporter member 14 | ||||
| DT Family | Major Facilitator Superfamily (MFS) | ||||
| Sugar Porter (SP) Family | |||||
| Tissue Specificity | Expressed mainly in testis. | ||||
| Function | This transporter may have a specific function related to spermatogenesis and facilitates glucose transport. | ||||
| Endogenous Substrate(s) | Glucose | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(γ) Outward/inward-facing Conformation |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
2-Deoxyglucose
|
Phase 1/2 | Drug Info | Cancer | 2A00-2F9Z | [1] |
| References | |||||
| 1 | The SLC2A14 gene, encoding the novel glucose/dehydroascorbate transporter GLUT14, is associated with inflammatory bowel disease. Am J Clin Nutr. 2017 Dec;106(6):1508-1513. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.